Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And Safety

ClinicalTrials.gov ID: NCT00375401

Public ClinicalTrials.gov record NCT00375401. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 10, 2026, 6:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 2-Year, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study To Evaluate The Long-Term Efficacy And Safety Of CP-945,598 In The Treatment Of Obese Subjects

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to examine the long-term weight loss and safety of CP-945,598 in obese adults

Study identification

NCT ID
NCT00375401
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pfizer
Industry
Enrollment
2,536 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2006 (Type not available)
Primary completion
Jan 2009 (Actual)
Completion
Jan 2009 (Actual)
Last update posted
Nov 7, 2012

2006 – 2009

United States locations

U.S. sites
74
U.S. states
33
U.S. cities
67
Facility City State ZIP Site status
Pfizer Investigational Site Fairhope Alabama 36532 —
Pfizer Investigational Site Huntsville Alabama 35801 —
Pfizer Investigational Site Mobile Alabama 36608 —
Pfizer Investigational Site La Jolla California 92037 —
Pfizer Investigational Site Oakland California 94609-3223 —
Pfizer Investigational Site San Diego California 92128 —
Pfizer Investigational Site San Diego California 92130 —
Pfizer Investigational Site Santa Ana California 92705 —
Pfizer Investigational Site Walnut Creek California 94598 —
Pfizer Investigational Site Longmont Colorado 80501 —
Pfizer Investigational Site Orlando Florida 32809 —
Pfizer Investigational Site Atlanta Georgia 30342 —
Pfizer Investigational Site Honolulu Hawaii 96814 —
Pfizer Investigational Site Chicago Illinois 60610 —
Pfizer Investigational Site Gurnee Illinois 60031 —
Pfizer Investigational Site Indianapolis Indiana 46260 —
Pfizer Investigational Site Wichita Kansas 67207 —
Pfizer Investigational Site Lexington Kentucky 40509 —
Pfizer Investigational Site Louisville Kentucky 40213 —
Pfizer Investigational Site Louisville Kentucky 40223 —
Pfizer Investigational Site Madisonville Kentucky 42431 —
Pfizer Investigational Site Baton Rouge Louisiana 70808 —
Pfizer Investigational Site Baton Rouge Louisiana 70809 —
Pfizer Investigational Site Scarborough Maine 04074 —
Pfizer Investigational Site Baltimore Maryland 21201 —
Pfizer Investigational Site Baltimore Maryland 21204 —
Pfizer Investigational Site Boston Massachusetts 02114 —
Pfizer Investigational Site Milford Massachusetts 01757 —
Pfizer Investigational Site North Dartmouth Massachusetts 02747 —
Pfizer Investigational Site Troy Michigan 48098 —
Pfizer Investigational Site Chaska Minnesota 55318 —
Pfizer Investigational Site Edina Minnesota 55435 —
Pfizer Investigational Site Minneapolis Minnesota 55415 —
Pfizer Investigational Site Waconia Minnesota 55387 —
Pfizer Investigational Site Kansas City Missouri 64114 —
Pfizer Investigational Site Hamilton New Jersey 08690 —
Pfizer Investigational Site Albuquerque New Mexico 87108 —
Pfizer Investigational Site Endwell New York 13760 —
Pfizer Investigational Site Kingston New York 12401 —
Pfizer Investigational Site Manlius New York 13104 —
Pfizer Investigational Site New York New York 10021-7903 —
Pfizer Investigational Site Rochester New York 14609 —
Pfizer Investigational Site Burlington North Carolina 27215 —
Pfizer Investigational Site Charlotte North Carolina 28211 —
Pfizer Investigational Site Charlotte North Carolina 28277 —
Pfizer Investigational Site Fargo North Dakota 58103 —
Pfizer Investigational Site Akron Ohio 44311 —
Pfizer Investigational Site Medford Oregon 97504 —
Pfizer Investigational Site Beaver Pennsylvania 15009 —
Pfizer Investigational Site Philadelphia Pennsylvania 19104 —
Pfizer Investigational Site Cumberland Rhode Island 02864 —
Pfizer Investigational Site Pawtucket Rhode Island 02860 —
Pfizer Investigational Site Greer South Carolina 29651 —
Pfizer Investigational Site Mt. Pleasant South Carolina 29464 —
Pfizer Investigational Site Bristol Tennessee 37620 —
Pfizer Investigational Site Kingsport Tennessee 37660 —
Pfizer Investigational Site Knoxville Tennessee 37920 —
Pfizer Investigational Site Nashville Tennessee 37203 —
Pfizer Investigational Site Austin Texas 78705 —
Pfizer Investigational Site Beaumont Texas 77701 —
Pfizer Investigational Site Dallas Texas 75246 —
Pfizer Investigational Site Dallas Texas 75390-8858 —
Pfizer Investigational Site Fort Worth Texas 76135 —
Pfizer Investigational Site Fort Worth Texas 76137 —
Pfizer Investigational Site Lake Jackson Texas 77566 —
Pfizer Investigational Site San Antonio Texas 78229 —
Pfizer Investigational Site Charlottesville Virginia 22911 —
Pfizer Investigational Site Norfolk Virginia 23502 —
Pfizer Investigational Site Richmond Virginia 23294 —
Pfizer Investigational Site Olympia Washington 98502 —
Pfizer Investigational Site Renton Washington 98057 —
Pfizer Investigational Site Morgantown West Virginia 26506-9136 —
Pfizer Investigational Site Milwaukee Wisconsin 53209 —
Pfizer Investigational Site Oregon Wisconsin 53575 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00375401, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 7, 2012 · Synced Oct 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00375401 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →